98
Views
8
CrossRef citations to date
0
Altmetric
Research Article

The Dose Related Effect of Steroids on Blast Reduction Rate and Event Free Survival in Children with Acute Lymphoblastic Leukemia

, &
Pages 489-495 | Published online: 01 Jul 2009

  • Jacquillat, C., Weil, M., Gemon, M.F., Auclerc, G., Loisel, I.P., Delobel, J., Flandrin, G., Schaison, G., Izrael, V, Bussel, A., Dresch, C., Weisgerber, C., Rain, D., Tanzer, J., Najean, Y., Seligmann, M., Boiron, M. and Bernard, I. (1973) "Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 99-Paris)", Cancer Research 33, 3278-3284.
  • Miller, D.R., Coccia, P.F., Bleyer, W.A., Lukens, J.N., Siegel, S.E., Sather, H.N. and Hammond, G.D. (1989) "Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group", Journal of Clinical Oncology 7, 1807-1815.
  • Gaynon, P.S., Bleyer, W.A., Steinherz, P.G., Finklestein, J.Z., Liftman, P., Miller, D.R., Reaman, G., Sather, H. and Hammond, G.D. (1990) "Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features", Medical and Pediatric Oncology 18, 273-279.
  • Riehm, H., Gadner, H., Henze, G., Kornhuber, B., Lampen, F., Niethammer, D., Reiter, A. and Schellong, G. (1990) "Results and significance of six randomized trials in four consecutive ALL-BFM studies", Hematology Blut Transfusion 33, 439-450.
  • Hutchinson, R., Bertolone, S., Cooper, H., Roskos, K., Welis, L., Heerema, N., Tamnous, R., Neerhout, R., Sather, H., Sailer, S., Hummell, D., Trigg, M. and Hammond, G. (1994) "Early marrow response predicts outcome for patients with low-risk ALL: result of CCG-1881", Proceedings of American Society for Clinical Oncology 13, 319, Abstract 1051.
  • Steinhetz, P.C., Gaynon, P.S., Breneman, J.C., Cherlow, I.M., Grossman, N.J., Kersey, I.H., Johnstone, H.S., Sather, H.N., Trigg, M.E., Chappell, R., Hammond, D. and Bleyer, W.A. (1996) "Cytoreduction and prognosis in acute lymphoblastic leukemia: the importance of early marrow response: report from the Childrens Cancer Group", Journal of Clinical Oncology 14, 389-398.
  • Nachman, I., Sather, H.N., Gaynon, P.S., Lukens, J.N., Wolff, L. and Trigg, M.E. (1997) "Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group", Journal of Clinical Oncology IS, 2222-2230.
  • Rautonen, J., Hovi, L. and Siimes, M.A. (1988) "Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia", Blood 71, 989-991.
  • Gajjar, A., Ribeiro, R., Hancock, M.L., Rivera, G.K., Mahmoud, H., Sandlund, J.T., Crist, W.M. and Pui, C.H. (1995) "Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia", Blood 86, 1292-1295.
  • Schrappe, M., Reiter, A. and Riehm, H. (1996) "Cytoreduction and prognosis in childhood acute lymphoblastic leukemia", Journal of Clinical Oncology 14, 2403-2406.
  • Griffin, T.C., Sinister, I.J., Buchanan, G.R., Murphy, S.B., Camilla, B.M. and Amylon, M.D. (2000) "Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study", Leukemia 14, 792-795.
  • Dordelmann, M, Reiter, A., Borkhardt, A., Ludwig, W.D., Gotz, N., Viehmann, S., Gadner, H., Riehm, H. and Schrappe, M. (1999) "Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia", Blood 94,1209-1217.
  • Yetgin, S., Gurgey, A., Tuncer, A.M., Cetin, M., Özbek, N., Sayli, T., Guler, E., Kara, A., Olcay, L., Dura, F., Glimruk, E., Atahan, L. and Tunçbilek, E. (1998) "A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acutelymphoblastic leukemia patients with randomization", Leukemia Research 22, 485-493.
  • Yetgin, S., Tuncer, M.A., Çetin, M., Gümrük, E., Yenicesu, I., Tunç, B., Oner, A.F., Toksoy, H., Koç, A., Asian, D., Özyürek, E., Olcay, L., Atahan, L., Tunçbilek, E. and Gürgey, A. (2002) "Benefit of high-dose methylprednisolone in comparison of conventional dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-period follow-up", Leukemia 16, In press.
  • Rivera, G.K., Raimondi, S.C., Hancock, M.L., Behm, E.G., Pui, C.H., Abromowitch, M., Mirro, Jr, J., Ochs, J.S., Look, A.T., Williams, D.L., Murphy, S.B., Dahl, G.V., Kalwinsky, D.K., Evans, W.E., Run, L.E., Simone, I.V. and Grist, W.M. (1991) "Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy", Lancet 337, 61 -66.
  • Reiter, A., Schrappe, M., Ludwig, W.D., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Lampert, F., Havers, W., Niethammer, D., et al. (1994) "Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86", Blood 84, 3122-3133.
  • Schwartz, C.L., Thompson, E.B., Gelber, R.D., Young, M.L., Chilton, D., Cohen, H.J. and Sallan, S.E. (2001) "Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia", Journal of Clinical Oncology 19, 1040-1046.
  • Arico, M., Basso, G., Mandelli, E, Rizzari, C., Colella, R., Barisone, E., Zanesco, L., Rondelli, R., Pession, A. and Masera, G. (1995) "Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia", Cancer 75, 1684-1693.
  • Felice, M.S., Zubizarreta, P.A., Alfaro, E.M. and Sackmann-Muriel, E (2001) 11ChUdIiOOd acute lymphoblastic leukemia: prognostic value of initial peripheral blood blast count in good responders to prednisone", Journal of Pediatric Hematology and Oncology 23, 411-415.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.